We investigated the relationship between antecedent conditions and risk factors and AD defined by blood-based biomarkers, P-tau 217 and P-tau 181, and comparing four groups: Asym/NEG, Asym/POS, Sym/NEG, Sym/POS as defined earlier. The gene discussed is MAPT; the disease is Alzheimer disease.